Literature DB >> 27745783

Sponsorship of National Health Organizations by Two Major Soda Companies.

Daniel G Aaron1, Michael B Siegel2.   

Abstract

INTRODUCTION: Obesity is a pervasive public health problem in the U.S. Reducing soda consumption is important for stemming the obesity epidemic. However, several articles and one book suggest that soda companies are using their resources to impede public health interventions that might reduce soda consumption. Although corporate sponsorship by tobacco and alcohol companies has been studied extensively, there has been no systematic attempt to catalog sponsorship activities of soda companies. This study investigates the nature, extent, and implications of soda company sponsorship of U.S. health and medical organizations, as well as corporate lobbying expenditures on soda- or nutrition-related public health legislation from 2011 to 2015.
METHODS: Records of corporate philanthropy and lobbying expenditures on public health legislation by soda companies in the U.S. during 2011-2015 were found through Internet and database searches.
RESULTS: From 2011 to 2015, the Coca-Cola Company and PepsiCo were found to sponsor a total of 95 national health organizations, including many medical and public health institutions whose specific missions include fighting the obesity epidemic. During the study period, these two soda companies lobbied against 29 public health bills intended to reduce soda consumption or improve nutrition.
CONCLUSIONS: There is surprisingly pervasive sponsorship of national health and medical organizations by the nation's two largest soda companies. These companies lobbied against public health intervention in 97% of cases, calling into question a sincere commitment to improving the public's health. By accepting funding from these companies, health organizations are inadvertently participating in their marketing plans.
Copyright © 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27745783     DOI: 10.1016/j.amepre.2016.08.010

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  15 in total

Review 1.  Ethics Guidelines in Environmental Epidemiology: Their Development and Challenges We Face.

Authors:  Shira Kramer; Colin L Soskolne
Journal:  Curr Environ Health Rep       Date:  2017-06

Review 2.  Global Implementation of Obesity Prevention Policies: a Review of Progress, Politics, and the Path Forward.

Authors:  Rodney Lyn; Erica Heath; Janhavi Dubhashi
Journal:  Curr Obes Rep       Date:  2019-12

3.  Six policy lessons relevant to cannabis legalization.

Authors:  Chelsea L Shover; Keith Humphreys
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-14       Impact factor: 3.829

4.  Lessons from Corporate Influence in the Opioid Epidemic: Toward a Norm of Separation.

Authors:  Jonathan H Marks
Journal:  J Bioeth Inq       Date:  2020-07-13       Impact factor: 1.352

5.  Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.

Authors:  Kent Buse; Sonja Tanaka; Sarah Hawkes
Journal:  Global Health       Date:  2017-06-15       Impact factor: 4.185

6.  Public health journals' requirements for authors to disclose funding and conflicts of interest: a cross-sectional study.

Authors:  Karim N Daou; Maram B Hakoum; Assem M Khamis; Lama Bou-Karroum; Ahmed Ali; Joseph R Habib; Aline T Semaan; Gordon Guyatt; Elie A Akl
Journal:  BMC Public Health       Date:  2018-04-23       Impact factor: 3.295

7.  Transforming Life: A Broad View of the Developmental Origins of Health and Disease Concept from an Ecological Justice Perspective.

Authors:  Susan L Prescott; Alan C Logan
Journal:  Int J Environ Res Public Health       Date:  2016-11-03       Impact factor: 3.390

8.  Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.

Authors:  Maram B Hakoum; Nahla Jouni; Eliane A Abou-Jaoude; Divina Justina Hasbani; Elias A Abou-Jaoude; Luciane Cruz Lopes; Mariam Khaldieh; Mira Zein Hammoud; Mounir Al-Gibbawi; Sirine Anouti; Gordon Guyatt; Elie A Akl
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

9.  Exploring why global health needs are unmet by research efforts: the potential influences of geography, industry and publication incentives.

Authors:  Alfredo Yegros-Yegros; Wouter van de Klippe; Maria Francisca Abad-Garcia; Ismael Rafols
Journal:  Health Res Policy Syst       Date:  2020-05-15

10.  Spaceship Earth Revisited: The Co-Benefits of Overcoming Biological Extinction of Experience at the Level of Person, Place and Planet.

Authors:  Susan L Prescott; Jeffrey S Bland
Journal:  Int J Environ Res Public Health       Date:  2020-02-21       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.